Results for cadila

Add to feed Create your own feed

Latest

Cadila Healthcare and Bayer (South East Asia) on Monday said that they have decided to extend the operations of their joint venture by three years with effect from June. @Cadila_Pharma 

Zydus Cadila May Seek Emergency Use Nod For Vaccine Next Week: Report

tweet picture

cadila'>Zydus Cadila likely to seek emergency use authorisation for its Covid vaccine next week

#VaccineForAll | #Zydus  Cadila likely to seek emergency use authorisation for its #COVIDVaccine  next week (From Agencies) @ZydusUniverse 

tweet picture

#Coronavirus | 'cadila'>Zydus Cadila@ZydusUniverse ) final analysis of vaccine is underway, it appears that vaccine results should be ready by July,' says Dr NK Arora, head of the National Vax Advisory Group in conversation with @ShereenBhan .

cadila'>Zydus Cadila likely to seek emergency authorisation for ZyCoV-D Covid-19 vaccine in 7-8 days

Vaccine manufacturer cadila'>Zydus Cadila has told the Centre that it could apply for emergency use authorisation for its Covid-19 vaccine ZyCoV-D in the next seven to ten days #CoronaVaccine  @pretasorter )

#ZydusCadila to seek emergency use authorisation for #COVID19  vaccine in India

EXPLAINED | The Science Behind Covid-19 Vaccines Approved by India #CovidVaccine  Cadila' alt='ZydusCadila' /'>#ZydusCadila 

Loading
Loading

Most relevant

Subject Expert Committee gives recommendations for the clinical trials of ZydusCadila's biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralising monoclonal antibodies (mAbs) that can emerge as one of the main treatments for mild COVID-19

Zydus seeks DCGI approval to undertake clinical trials for monoclonal antibodies cocktail that can neutralise #COVID  infection: cadila'>Zydus Cadila

Drugs Controller General of India (DGCI) approves emergency use for ZydusCadila's Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate #COVID19  infection in adults.

tweet picture

Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by cadila'>Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey.

tweet picture

3 vaccines at clinical trial stage in India. Cadila and Bharat Biotech have completed phase-I trials. Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances: Prof (Dr.) Balram Bhargava, DG, ICMR

tweet picture

OnCNBCTV18 | @sushilkedia , founder, @kedianomics  tells @_anujsinghal  & @SurabhiUpadhyay  that he sees #Nifty  range at 9,450-9,050 & that he is positive on Cadila & Aurobindo Pharma#TrackingTheTechnicals 

Permission for Phase I/II clinical trial for #COVID19  vaccine of cadila'>Zydus Cadila granted today as a rapid response after recommendation by Subject Expert Committee: Health Ministry official

Pharmaceutical industry has significantly increased the production of hydroxychloroquine (HCQ). 20 crore tablets of HCQ have been produced by the industry this month: Pankaj Patel, CEO of cadila'>Zydus Cadila, in Ahmedabad#COVID19 

tweet picture

Manufacturing plant of Cadila Pharmaceuticals at Dholka in Ahmedabad, Gujarat has been closed following 26 of its employees testing positive for #COVID19 . Deep sanitization of the plant & its surroundings is being undertaken: Cadila Pharmaceuticals

cadila'>Zydus Cadila CEO Pankaj Patel has said that the pharmaceutical industry has significantly increased the production of hydroxychloroquine (HCQ).

Loading
Loading